JPMorgan Names New Leaders for Biopharma, Life Sciences Banking

JPMorgan Chase & Co. has named Chris Gartin and Mike Connor co-heads of North America biopharma investment banking, as the firm reorganizes the leadership across some of its health-care dealmaking groups.

Kyle Finegan was also named head of North America life science tools and diagnostics, according to an internal company memo reviewed by Bloomberg News. In London, Henry Capper was named head of biopharma for Europe, Middle East and Africa while John Pissanos has become head of life science tools and diagnostics for EMEA.